[Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].

Abstract excerpt

Mastocytosis is characterized by an abnormal proliferation and accumulation of mast cells (MC) in one or more organ systems. The current WHO classification discriminates cutaneous mastocytosis (CM) and various forms of systemic mastocytosis (SM). While CM usually follows a bening and often self-limiting course, SM is a persistent disease in which a somatic KIT mutation at codon 816 (i.e. D816V) is detectable in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Benzamides
• Share to Imatinib Mesylate
• Share to Mastocytosis